Trial Profile
A clinical study of fosfomycin (CONTEPO) in pediatric patients with complicated urinary tract infections (cUTI)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Fosfomycin (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions
- 31 Jul 2018 New trial record
- 24 Jul 2018 According to a Nabriva Therapeutics media release, this study has been initiated.